Menopause
Pipeline by Development Stage
Drug Modality Breakdown
Women's Health is a $989M market with mature, consolidated portfolios dominated by legacy hormone therapies and specialty oncology agents.
Key Trends
- Heavy concentration in estrogen receptor agonists and single-blockbuster dependency (INLYTA 47% of market)
- Multiple patent cliffs 2027-2030 creating near-term revenue pressure and consolidation risk
- Hiring concentrated in commercial and specialty recruitment, not R&D expansion
Career Verdict
Viable but cautious entry point—stable commercial roles available, but limited innovation pipeline and impending LOE events suggest a mature market in defensive posture rather than growth mode.
AI-generated market analysis based on FDA, CMS, ClinicalTrials.gov, and hiring data
Market Leaders
| # | Product | Company | Revenue | Share | Stage | Trend | LOE |
|---|---|---|---|---|---|---|---|
| 1 | INLYTA (axitinib) | Pfizer | $0.467B | 47% | Peak | Stable | 11.2yr |
| 2 | KORLYM (mifepristone) | Corcept Therapeutics | $0.229B | 23% | Peak | Stable | 12.2yr |
| 3 | LUPRON DEPOT (leuprolide acetate) | AbbVie | $0.129B | 13% | LOE Approaching | Declining | |
| 4 | ESTRING (estradiol) | Pfizer | $0.050B | 5% | LOE Approaching | Declining | |
| 5 | PREMPRO (conjugated estrogens/medroxyprogesterone) | Pfizer | $0.040B | 4% | LOE Approaching | Declining |
Drug Class Breakdown
single-product dominance (INLYTA)
concentrated in specialty reproductive health
legacy product with pending LOE pressure
fragmented across 17 products, majority LOE-approaching
minor indication-specific use
niche positioning, small market share
Career Outlook
StableWomen's Health is a mature, consolidated market where career growth is incremental rather than exponential. Pfizer and AbbVie control ~61% of spending via blockbuster and legacy products, creating stable but competitive commercial environments. Impending patent cliffs (2027-2030) and fragmented early-stage pipeline suggest cost containment and defensive strategy dominance over expansion, meaning fewer senior advancement slots and limited innovation-driven upside. Opportunity exists in specialty segments (fertility platforms, digital health, device innovation) outside traditional pharma.
Breaking In
Target specialty commercial roles (MSL, outcomes research) or non-traditional employers (Progyny, digital health startups, device firms) rather than incumbent pharma, which offers less differentiation for new entrants.
For Experienced Professionals
Experienced professionals should assess portfolio defensibility and patent cliff timing before joining a company; AbbVie and Pfizer offer scale but entail consolidation risk, while boutique firms (Corcept, Duchesnay) offer strategic leverage in niche areas.
In-Demand Skills
Best For
Hiring Landscape
Women's Health hiring totals 117 jobs, but data shows significant reporting gaps (many major companies report 0 jobs despite large portfolios). Visible hiring is concentrated in Viatris (40 jobs, likely manufacturing/supply chain post-spinoff), Progyny (29 jobs, fertility/reproductive benefits platform), and specialized device/diagnostics firms (GE HealthCare, Caldera Medical, Natera). Commercial roles dominate disclosed positions (65 of 109 departmental roles), with IT second (7 roles at $222K avg, reflecting digital health emphasis).
Top Hiring Companies
By Department
Commercial and specialty sales roles offer stable near-term opportunity, but modest average salary ($82K commercial) and portfolio maturity suggest limited high-growth compensation upside; IT roles offer premium but are scarce.
On Market (1)
Approved therapies currently available
Competitive Landscape
28 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 1,046,653 patients across 50 trials
Cardiometabolic Consequences of the Loss of Ovarian Function
the Effects of Different Therapy Regimens on Menopausal Sleep Disorders
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
Bioenergetic Effects of Aging and Menopause (BEAM)
Estrogen and the Urogenital Microbiome in GSM
Effect of Nuvigil on Fatigue
Treating Climacteric Symptoms With a Complex Homeopathic Remedy
Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women
Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)
Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations
Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women
Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints
Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Qing'E Formula Therapy on Menopausal Symptoms
Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
Efficacy Study of Progesterone Tablet in Post-menopausal Women
Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation
Affect of Duavive on Mood & Anxiety Symptoms
Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation
Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore
Hot Water Therapy for the Treatment of Menopause-related Hot Flashes
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
A Study to Learn More About the Menopausal Hormone Therapies in Korea
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
Effects of Pulse Consumption on Bone Health of Postmenopausal Women
Effect of 4 Weeks of Citrulline and Glutathione Supplementation on Arterial Function
Dose Finding Evaluation of Kudzu Root Extract in Women With Menopause Symptoms
Blueberries for Improving Vascular Endothelial Function in Postmenopausal Women With Elevated Blood Pressure
The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.
A Prospective Multicenter Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia
Brown Adipose Tissue Activity in Pre- and Postmenopausal Women
Effects of a Recreational Team Handball-based Programme on Health and Physical Fitness of Postmenopausal Women
Related Jobs in Women's Health
General Medicines, Commercial Director, Menopause
Urology Gynecology Sales Representative - Future Opportunity
Territory Representative - Birmingham
Medical Science Liaison, Women's Health
Medical Director, Women’s Health - MFM
Scientist, Reproductive & Molecular Biology
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.